But, if cancer patients really want the drug, they can pay out of pocket for it. Your five months of living aren't worth $36,000 to the government.
Taylor said the government made the decision on Avastin based on the cost of the drug -- which would increase costs to the province's health plan by about $6.5 million -- versus its effectiveness.
In conjunction with chemotherapy, Avastin has been shown in clinical trials to add an average of five months to the lifespan of patients with incurable colorectal cancer.
The government will allow patients to pay for the pricey drug themselves at a cost of about $36,000 a year.